4//SEC Filing
Schwartzberg Gil 4
Accession 0001493152-21-008965
CIK 0001335105other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 9:09 PM ET
Size
12.2 KB
Accession
0001493152-21-008965
Insider Transaction Report
Form 4
Schwartzberg Gil
10% Owner
Transactions
- Award
Option to Purchase Common Stock
2021-04-09+250,000→ 250,000 totalExercise: $3.20From: 2021-04-09Exp: 2026-04-01→ Common (250,000 underlying)
Holdings
- 105,264
Warrant to Purchase Common Stock
Exercise: $5.70From: 2020-11-30Exp: 2025-11-30→ Common (105,264 underlying) - 83,333(indirect: By Trust)
Warrant to Purchase Common Stock
Exercise: $6.00From: 2018-12-07Exp: 2022-11-30→ Common (83,333 underlying) - 83,333
Options to Purchase Common Stock
Exercise: $3.00From: 2016-01-28Exp: 2024-01-28→ Common (83,333 underlying) - 291,667(indirect: By Trust)
Options to Purchase Common Stock
Exercise: $3.00From: 2015-01-28Exp: 2024-01-28→ Common (291,667 underlying) - 83,333(indirect: By Trust)
Warrant to Purchase Common Stock
Exercise: $6.00From: 2018-12-07Exp: 2022-11-30→ Common (83,333 underlying)
Footnotes (1)
- [F1]On April 9, 2021, in connection with his appointment to the Company's Board of Directors, the reporting person was granted stock options to purchase an aggregate of 250,000 shares vesting 50% on the grant date and the remainder vesting on the last day of each subsequent calendar quarter until fully vested.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001472409
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 9:09 PM ET
- Size
- 12.2 KB